Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 478,427 |
|
|||||
| News | - | ||||||
| Day High | 58.69 | Low High |
|||||
| Day Low | 54.93 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Keros Therapeutics Inc | KROS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.50 | 0.90% | 56.28 | 18:51:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 56.15 | 54.93 | 58.69 | 55.19 | 55.78 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,148 | 478,427 | $ 56.38 | $ 26,974,186 | - | 27.02 - 73.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:50:17 | formt | 100 | $ 56.28 | USD |
Keros Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.99B | 35.98M | - | 151k | -152.99M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Keros Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KROS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 57.22 | 61.33 | 54.93 | 58.18 | 302,923 | -0.94 | -1.64% |
| 1 Month | 67.27 | 67.49 | 54.93 | 61.76 | 276,681 | -10.99 | -16.34% |
| 3 Months | 57.94 | 73.00 | 50.10 | 62.27 | 371,729 | -1.66 | -2.87% |
| 6 Months | 28.20 | 73.00 | 27.02 | 49.55 | 389,861 | 28.08 | 99.57% |
| 1 Year | 44.90 | 73.00 | 27.02 | 45.97 | 297,262 | 11.38 | 25.35% |
| 3 Years | 63.54 | 73.00 | 24.38 | 45.27 | 221,590 | -7.26 | -11.43% |
| 5 Years | 20.10 | 88.80 | 20.10 | 46.98 | 197,655 | 36.18 | 180.00% |
Keros Therapeutics Description
| Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. |
